These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 22551846

  • 1. Intraoperative use of low-dose recombinant activated factor VII during thoracic aortic operations.
    Andersen ND, Bhattacharya SD, Williams JB, Fosbol EL, Lockhart EL, Patel MB, Gaca JG, Welsby IJ, Hughes GC.
    Ann Thorac Surg; 2012 Jun; 93(6):1921-8; discussion 1928-9. PubMed ID: 22551846
    [Abstract] [Full Text] [Related]

  • 2. Treatment of refractory bleeding after cardiac operations with low-dose recombinant activated factor VII (NovoSeven): a propensity score analysis.
    Gelsomino S, Lorusso R, Romagnoli S, Bevilacqua S, De Cicco G, Billè G, Stefàno P, Gensini GF.
    Eur J Cardiothorac Surg; 2008 Jan; 33(1):64-71. PubMed ID: 17996457
    [Abstract] [Full Text] [Related]

  • 3. Use of recombinant activated factor VII concentrate to control postoperative hemorrhage in complex cardiovascular surgery.
    Bowman LJ, Uber WE, Stroud MR, Christiansen LR, Lazarchick J, Crumbley AJ, Kratz JM, Toole JM, Crawford FA, Ikonomidis JS.
    Ann Thorac Surg; 2008 May; 85(5):1669-76; discussion 1676-7. PubMed ID: 18442563
    [Abstract] [Full Text] [Related]

  • 4. Recombinant activated factor VII for refractory bleeding after acute aortic dissection surgery: a propensity score analysis.
    Tritapepe L, De Santis V, Vitale D, Nencini C, Pellegrini F, Landoni G, Toscano F, Miraldi F, Pietropaoli P.
    Crit Care Med; 2007 Jul; 35(7):1685-90. PubMed ID: 17522585
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A Propensity-Score Matched Analysis on Outcomes Using Recombinant Activated Factor VII in Pediatric Cardiac Surgery.
    Li Y, Zhao W, Luo Q, Wu X, Ding J, Yan F.
    J Cardiothorac Vasc Anesth; 2019 May; 33(5):1269-1275. PubMed ID: 30795967
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Thrombotic risk of recombinant factor seven in pediatric cardiac surgery: a single institution experience.
    Karsies TJ, Nicol KK, Galantowicz ME, Stephens JA, Kerlin BA.
    Ann Thorac Surg; 2010 Feb; 89(2):570-6. PubMed ID: 20103344
    [Abstract] [Full Text] [Related]

  • 11. Characteristics Associated With Mortality in 372 Patients Receiving Low-Dose Recombinant Factor VIIa (rFVIIa) for Cardiac Surgical Bleeding.
    Baral P, Cotter E, Gao G, He J, Wirtz K, Sharma A, Zorn Iii T, Muehlebach G, Flynn B.
    J Cardiothorac Vasc Anesth; 2019 Aug; 33(8):2133-2140. PubMed ID: 30772178
    [Abstract] [Full Text] [Related]

  • 12. The use of recombinant coagulation factor VIIa in uncontrolled postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass.
    Pychyńska-Pokorska M, Moll JJ, Krajewski W, Jarosik P.
    Pediatr Crit Care Med; 2004 May; 5(3):246-50. PubMed ID: 15115562
    [Abstract] [Full Text] [Related]

  • 13. Outcomes Following Three-Factor Inactive Prothrombin Complex Concentrate Versus Recombinant Activated Factor VII Administration During Cardiac Surgery.
    Harper PC, Smith MM, Brinkman NJ, Passe MA, Schroeder DR, Said SM, Nuttall GA, Oliver WC, Barbara DW.
    J Cardiothorac Vasc Anesth; 2018 Feb; 32(1):151-157. PubMed ID: 29217234
    [Abstract] [Full Text] [Related]

  • 14. Factor VIII inhibitor bypass activity and recombinant activated factor VII in cardiac surgery.
    Rao VK, Lobato RL, Bartlett B, Klanjac M, Mora-Mangano CT, Soran PD, Oakes DA, Hill CC, van der Starre PJ.
    J Cardiothorac Vasc Anesth; 2014 Oct; 28(5):1221-6. PubMed ID: 25281040
    [Abstract] [Full Text] [Related]

  • 15. A role for very low-dose recombinant activated factor VII in refractory bleeding after cardiac surgery: Lessons from an observational study.
    Hoffmann T, Assmann A, Dierksen A, Roussel E, Ullrich S, Lichtenberg A, Albert A, Sixt S.
    J Thorac Cardiovasc Surg; 2018 Oct; 156(4):1564-1573.e8. PubMed ID: 29884487
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Impact on postoperative bleeding and cost of recombinant activated factor VII in patients undergoing heart transplantation.
    Hollis AL, Lowery AV, Pajoumand M, Pham SM, Slejko JF, Tanaka KA, Mazzeffi M.
    Ann Card Anaesth; 2016 Oct; 19(3):418-24. PubMed ID: 27397445
    [Abstract] [Full Text] [Related]

  • 20. Effective management of refractory postcardiotomy bleeding with the use of recombinant activated factor VII.
    Filsoufi F, Castillo JG, Rahmanian PB, Scurlock C, Fischer G, Adams DH.
    Ann Thorac Surg; 2006 Nov; 82(5):1779-83. PubMed ID: 17062247
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.